Cancer Drug and Imaging Techniques were discussed
Non-invasive imaging of the pharmacodynamics properties of a new cancer drug with the PET device was discussed at the Faculty of Pharmacy, Cyprus International University (CIU).
Assist. Prof. Dr. Seth Gammon, researcher at the MD Anderson Cancer Centre of the University of Texas, gave information about how to use the PET device to view the interaction of the new cancer drug with the tumours. Assist. Prof. Dr. Seth Gammon stated that a radioactive sugar molecule was given to the patient at PET and this is perceived as sugar by the body and captured by cells at high metabolic rate. Gammon said that with the device the spread of the disease has been determined correctly by the metabolic and anatomical information and this technology is developed to observe the drug-tumour interaction. Dr. Gammon pointed out that this would allow the necessary surgery to be done and it is also used to observe the drug efficacy.
Assist. Prof. Dr. Ender Volkan, the Vice Dean of the Faculty of Pharmacy and a member of the Biotechnology Research Centre stated that studies were conducted by the CIU Faculty of Pharmacy and the Biotechnology Research Centre on cancer which is a disease that is encountered in the Turkish Republic of Northern Cyprus (TRNC) frequently. Assist. Prof. Dr. Volkan said IACS-010759 is a new name given to a cancer drug tumour cells to prevent transmission of nutrients and energy by causing death of a tumour cell and he explained how the interaction of the drug with the tumour in the body was visualized with the PET device and he said they shared with the CIU academics and students how it is viewed by a PET device.
At the seminar held at the CIU Çevik Uraz Centre Conference Hall, where a lot of Faculty of Pharmacy students were participated, Assist. Prof. Dr. Seth Gammon answered students’ questions.